The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis

Microbes and Infection

Volumn 2, Issue 6, 2000, Pages 659-669

  Slayden, Richard A ^a   Barry III, Clifton E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Catalase; Isoniazid; KatG; Pro drug; Tuberculosis

Indexed keywords

ISONIAZID;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL GENETICS; GENE MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0034084624     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00359-2     Document Type: Review

References (109)

1. McKenzie D., Malone L., Kushner S., Oleson J., Subbarow J. The effect of nicotinic acid amide on experimental tuberculosis of white mice. Lab. Clin. M. Vol. 1, 3 vols:1948;1249-1253.
2. Winder F.G. Ratledge C, Standford J. The Biology of the Mycobacteria. 33:1982;353-438 Academic Press, London.
3. Meyer H., Mally J. Uber hydrazinderivate de pyridincarbonsauren. Montashefte fur Chemie. 65:1912;393-414.
4. Bernstein J., Lott W.A., Steinberg B.A., Yale H.L. Chemotherapy of experimental tuberculosis. Am. Rev. Tuberc. 27:1952;357-364.
5. Mdluli K., Swanson J., Fischer E., Lee R.E., Barry III C.E. Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol. Microbiol. 149:1998;1223-1233.
6. Bass J.B., Farer L.S., Hopewell P.C., O'Brien R., Jacobs R.F., Ruben F., Snider D.E., Thornton G. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am. J. Respir. Crit. Care M. 278:1994;1359-1374.
7. Moore M., Onorato I.M., McCray E., Castro K.G. Trends in drug-resistant tuberculosis in the United States, 1993-1996. JAMA. 215:1997;833-837.
8. Lee R.E., Brennan P.J., Besra G.S. Mycobacterium tuberculosis cell envelope. Curr. Top. Microbiol. Immunol. 64:1996;1-27.
9. Brennan P.J., Nikaido H. The envelope of mycobacteria. Annu. Rev. Biochem. 37:1995;29-63.
10. Barry III C.E., Lee R.E., Mdluli K., Sampson A.E., Schroeder B.G., Slayden R.A., Yuan Y. Mycolic acids: structure, biosynthesis and physiological functions. Prog. Lipid Res. 1998;143-179.
11. Takayama K., Davidson L.A. Antimycobacterial drugs that inhibit mycolic acid synthesis. Trends Biol. Sci. 358:1979;280-282.
12. Zhang Y., Heym B., Allen B., Young D., Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (London). 65:1992;591-593.
13. Middlebrook G. Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. Am. Rev. Tuberc. 69:1952;765-767.
14. Middlebrook G. Isoniazid-resistance and catalase activity of tubercle bacilli. Am. Rev. Tuberc. 8:1954;471-472.
15. Zhang Y., Garbe T., Young D. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol. Microbiol. 175:1993;521-524.
16. Heym B., Zhang Y., Poulet S., Young D., Cole S.T. Characterization of thekatG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. J. Bacteriol. 110:1993;4255-4259.
17. Diaz G.A., Wayne L.G. Isolation and characterization of catalase produced by Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 149:1974;312-319.
18. Devi B.G., Shaila M.S., Ramakrishnan T., Gopinathan K.P. The purification and properties of peroxidase in Mycobacterium tuberculosis H37Rv and its possible role in the mechanism of action of isonicotinic acid hydrazide. Biochem. J. 272:1975;187-197.
19. Nagy J.M., Cass A.E., Brown K.A. Purification and characterization of recombinant catalase-peroxidase, which confers isoniazid sensitivity in Mycobacterium tuberculosis. J. Biol. Chem. 272:1997;31265-31271.
20. Johnsson K., Froland W.A., Schultz P.G. Overexpression, purification, characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis. J. Biol. Chem. 176:1997;2834-2840.
21. Wengenack N.L., Uhl J.R., Stamand A.L., Tomlinson A.J., Benson L.M., Naylor S., Kline B.C., Cockerill F.R., Rusnak F. Recombinant Mycobacterium tuberculosis KatG (S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J. Infect. Dis. 338:1997;722-727.
22. Saint-Joanis B., Souchon H., Wilming M., Johnsson K., Alzari P.M., Cole S.T. Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis. Biochem. J. 118:1999;753-760.
23. Magliozzo R.S., Marcinkeviciene J.A. Evidence for isoniazid oxidation by oxyferrous mycobacterial catalase-peroxidase. J. Am. Chem. Soc. 272:1996;11303-11304.
24. Magliozzo R.S., Marcinkeviciene J.A. The role of Mn (II)-peroxidase activity in mycobacterial catalase-peroxidase in activation of the antibiotic isoniazid. J. Biol. Chem. 38:1997;8867-8870.
25. Youatt J. The metabolism of isoniazid and other hydrazides by Mycobacteria. Aust. J. Exp. Biol. Med. Sci. 14:1960;245-250.
26. Youatt J. The formation of 4-pyridylmethanol from isonicotininc acid hydrazide (isoniazid) by mycobacteria. Aust. J. Chem. 40:1961;308-311.
27. Youatt J. The metabolism of isoniazid and pyridine aldehydes by Mycobacteria. Aust. J. Biol. Med. Sci. 323:1962;191-205.
28. Hillar A., Loewen P.C. Comparison of isoniazid oxidation catalyzed by bacterial catalase-peroxidases and horseradish peroxidase. Arch. Biochem. Biophys. 27:1995;438-446.
29. Shoeb H.A., Bernard U., Bowman J., Ottolenghi A.C., Merola A.J. Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 27:1985;404-407.
30. Shoeb H.A., Bernard U., Bowman J., Ottolenghi A.C., Merola A.J. Enzymatic and nonenzymatic superoxide-generating reactions of isoniazid. Antimicrob. Agents Chemother. 27:1985;408-412.
31. Shoeb H.A., Bernard U., Bowman J., Ottolenghi A.C., Merola A.J. Peroxidase-mediated oxidation of isoniazid. Antimicrob. Agents Chemother. 9:1985;399-403.
32. Goodwin D.C., Aust S.D., Grover T.A. Free radicals produced during the oxidation of hydrazines by hypochlorous acid. Chem. Res. Toxicol. 180:1996;1333-1339.
33. Zinner K., Vidigal C.C.C., Duran N., Cilsento G. Oxidation of isonicotinic acid hydrazide by the peroxidase system. Arch. Biochem. Biophys. 84:1977;452-458.
34. Wolman Y., Gallop P.M., Patchornid A., Berger A. Peptide synthesis via oxidative activation of acid hydrazides. J. Am. Chem. Soc. 116:1962;1889-1892.
35. Johnsson K., Schultz P.G. Mechanistic studies of the oxidation of isoniazid by the catalase-peroxidase from Mycobacterium tuberculosis. J. Am. Chem. Soc. 38:1994;7425-7426.
36. Wilming M., Johnsson K. Spontaneous formation of the bioactive form of the tuberculosis drug isoniazid. Angew. Chem. Int. 279:1999;2588-2590.
37. Rozwarski D.A., Grant G.A., Barton D.H.R., Jacobs W.R., Sacchettini J.C. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science. 180:1998;98-102.
38. Miesel L., Weisbrod T.R., Marcinkeviciene J.A., Bittman R., Jacobs W.R. NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis. J. Bacteriol. 66:1998;2459-2467.
39. +-binding proteins in mycobacterial INH resistance. Infect. Immun. 181:1998;5099-5106.
40. Payton M., Auty R., Delgoda R., Everett M., Sim E. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. J. Bacteriol. 63:1999;1343-1347.
41. Rouse D.A., Morris S.L. Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis. Infect. Immun. 40:1995;1427-1433.
42. Victor T.C., Pretorius G.S., Felix J.V., Jordaan A.M., Van Helden P.D., Eisenach K.D. katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis are not infrequent [letter]. Antimicrob. Agents Chemother. 14:1996;1572.
43. Zhang Y., Young D. Strain variation in the katG region of Mycobacterium tuberculosis. Mol. Microbiol. 15:1994;301-308.
44. Heym B., Alzari P.M., Honore N., Cole S.T. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol. Microbiol. 41:1995;235-245.
45. Kelley C.L., Rouse D.A., Morris S.L. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 168:1997;2057-2058.
46. Stoeckle M.Y., Guan L., Riegler N., Weitzman I., Kreiswirth B., Kornblum J., Laraque F., Riley L.W. Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City. J. Infect. Dis. 169:1993;1063-1065.
47. Altamirano M., Marostenmaki J., Fitzgerald A.W.M., Black W.A., Smith J.A. Mutations in the catalase peroxidase gene from isoniazid-resistant Mycobacterium tuberculosis isolates. J. Infect. Dis. 173:1994;1162-1165.
48. Musser J.M., Kapur V., Williams D.L., Kreiswirth B.N., Van Soolingen D., Van Embden J.D. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 40:1996;196-202.
49. Marttila H.J., Soini H., Huovinen P., Viljanen M.K. katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob. Agents Chemother. 42:1996;2187-2189.
50. Marttila H.J., Soini H., Eerola E., Vyshnevskaya E., Vyshnevskiy B.I., Otten T.F., Vasilyef A.V., Viljanen M.K. A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob. Agents Chemother. 22:1998;2443-2445.
51. Rouse D.A., Devito J.A., Li Z., Byer H., Morris S.L. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol. Microbiol. 37:1996;583-592.
52. Wengenack N.L., Todorovic S., Yu L., Rusnak F. Evidence for differential binding of isoniazid by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG (S315T). Biochemistry. 39:1998;15825-15834.
53. Rouse D.A., Li Z., Bai G.H., Morris S.L. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39:1995;2472-2477.
54. Pretorius G.S., Van Helden P.D., Sirgel F., Eisenach K.D., Victor T.C. Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare. Antimicrob. Agents Chemother. 176:1995;2276-2281.
55. Lee A.S.G., Tang L.L.H., Lim I.H.K., Ling M.L., Tay L., Wong S.Y. Lack of clinical significance for the common arginine-to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore. J. Infect. Dis. 26:1997;1125-1126.
56. Nagy J.M., Jesmin J., Servos S., Cass A.E., Brown K.A. Site-directed mutants of the catalase-peroxidase from Mycobacterium tuberculosis. Biochem. Soc. Trans. 69:1998;S281.
57. Morse W.C., Weiser O.L., Kuhns D.M., Fusillo M., Dail M.C., Evans J.R. Study of the virulence of isoniazid-resistant tubercle bacilli in guinea pigs and mice. Am. Rev. Tuberc. 86:1954;464-468.
58. Mitchison D.A., Selkon J.B., Lloyd J. Virulence in the guinea-pig, susceptibility to hydrogen peroxide, catalase activity of isoniazid-sensitive tubercle bacilli from South Indian and British patients. J. Path. Bacteriol. 118:1963;377-386.
59. Middlebrook G., Cohn M.L. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science. 15:1953;297-299.
60. Wilson T.M., Lisle G.W.D., Collins D.M. Effect of inhA and katG on isoniazid resistance and virulence ofMycobacterium bovis. Mol. Microbiol. 177:1995;1009-1015.
61. Li Z., Kelley C., Collins F., Rouse D., Morris S. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J. Infect. Dis. 272:1998;1030-1035.
62. Sherman D.R., Mdluli K., Hickey M.J., Arain T.M., Morris S.L., Barry III C.E., Stover C.K. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science. 35:1996;1641-1643.
63. Telenti A., Honore N., Bernasconi C., March J., Ortega A., Heym B., Takiff H.E., Cole S.T. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 17:1997;719-723.
64. Rinder H., Thomschke A., Rusch-Gerdes S., Bretzel G., Feldmann K., Rifai M., Loscher T. Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis. 41:1998;508-511.
65. Sreevatsan S., Pan X., Zhang Y., Deretic V., Musser J.M. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob. Agents Chemother. 2:1997;600-606.
66. Storz G., Imlay J.A. Oxidative stress. Curr. Opin. Microbiol. 37:1999;188-194.
67. Rosner J.L. Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid. Antimicrob. Agents Chemother. 92:1993;2251-2253.
68. Sherman D.R., Sabo P.J., Hickey M.J., Arain T.M., Mahairas G.G., Yuan Y., Barry III C.E., Stover C.K. Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. Proc. Natl. Acad. Sci. USA. 17:1995;6625-6629.
69. Deretic V., Philipp W., Dhandayuthapani S., Mudd M.H., Curcic R., Garbe T., Heym B., Via L.E., Cole S.T. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Mol. Microbiol. 14:1995;889-900.
70. Deretic V., Pagan-Ramos E., Zhang Y., Dhandayuthapani S., Via L.E. The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid. Nat. Biotechnol. 93:1996;1557-1561.
71. Zhang Y., Dhandayuthapani S., Deretic V. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid. Proc. Natl. Acad. Sci. USA. 178:1996;13212-13216.
72. Dhandayuthapani S., Zhang Y., Mudd M.H., Deretic V. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis. J. Bacteriol. 3:1996;3641-3649.
73. McClatchy J.K. Mechanism of action of isoniazid on Mycobacterium bovis strain BCG. Infect. Immun. 11:1971;530-534.
74. Tsukamura M., Tsukamura S. Isotopic studies on the effect of isoniazid on protein synthesis of mycobacteria. Jap. J. Tuberc. 4:1963;14-17.
75. Takayama K., Wang L., Merkal R.S. Scanning electron microscopy of the H37Ra strain of Mycobacterium tuberculosis exposed to isoniazid. Antimicrob. Agents Chemother. 40:1973;62-65.
76. Bardou F., Quemard A., Dupont M.A., Horn C., Marchal G., Daffe M. Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins. Antimicrob. Agents Chemother. 7:1996;2459-2467.
77. Takayama K., Keith A.D., Snipes W. Effect of isoniazid on the protoplasmic viscosity in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 117:1975;22-24.
78. Winder F.G.A., Collins P., Rooney S.A. Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope. Biochem. J. 177:1970;27.
79. Winder F.G., Rooney S.A. The effects of isoniazid on the carbohydrates of Mycobacterium tuberculosis BCG. J. Gen. Microbiol. 63:1970;355-368.
80. Winder F.G., Collins P.B. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. J. Gen. Microbiol. 2:1970;41-48.
81. Takayama K., Wang L., David H.L. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, viability of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 110:1972;29-35.
82. Takayama K., Armstrong E.L., David H.L. Restoration of mycolate synthetase activity in Mycobacterium tuberculosis exposed to isoniazid. Am. Rev. Respir. Dis. 16:1974;43-48.
83. Takayama K., Schnoes H.K., Armstrong E.L., Boyle R.W. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. J. Lipid Res. 16:1975;308-317.
84. Davidson L.A., Takayama K. Isoniazid inhibition of the synthesis of monounsaturated long-chain fatty acids in Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 1:1979;104-105.
85. Takayama K., Davidson L.A. Hahn F.E. Antibiotics: Mechanism of action of antibacterial agents. 40:1979;98-119 Springer-Verlag, Berlin.
86. Garbe T.R., Hibler N.S., Deretic V. Isoniazid induces expression of the antigen 85 complex in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 276:1996;1754-1756.
87. Belisle J.T., Vissa V.D., Sievert T., Takayama K., Brennan P.J., Besra G.S. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogensis. Science. 263:1997;1420-1422.
88. Banerjee A., Dubnau E., Quemard A., Balasubramanian V., Um K.S., Wilson T., Collins D., Jacobs W.R. Jr, Lisle G. de inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 34:1994;227-230.
89. Quemard A., Sacchettini J.C., Dessen A., Vilcheze C., Bittman R., William R., Jacobs W.R. Jr., Blanchard J.S. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry. 118:1995;8235-8241.
90. Quemard A., Dessen A., Sugantino M., Sacchettini J.C., Blanchard J.S. Binding of catalase-peroxidase-activated isoniazid to wild type and mutant Mycobacterium tuberculosis enoyl-ACP reductases. J. Am. Chem. Soc. 178:1996;1561-1562.
91. Basso L.A., Zheng R., Musser J.M., Jacobs W.R. Jr., Blanchard J.S. Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates. J. Infect. Dis. 117:1998;769-775.
92. Johnsson K., King D.S., Schultz P.G. Studies on the mechanism of action of isoniazid and ethionamide in the chemotherapy of tuberculosis. J. Am. Chem. Soc. 118:1995;5009-5010.
93. Basso L.A., Zheng R., Blanchard J.S. Kinetics of inactivation of WT and C243S mutant of Mycobacterium tuberculosis enoyl reductase by activated isoniazid. J. Am. Chem. Soc. 119:1996;11301-11302.
94. Zabinski R.F., Blanchard J.S. The requirement for manganese and oxygen in the isoniazid-dependent inactivation of Mycobacterium tuberculosis enoyl reductase. J. Am. Chem. Soc. 267:1997;2331-2332.
95. Dessen A., Quenmard A., Blanchard J.S., Sacchettini J.C. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science. 346:1995;1638-1641.
96. Ristow M., Monlig M., Rifal M., Schatz H., Feldmann K., Pfeliffer A. New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet. 179:1995;502-503.
97. Cingolani A., Antinori A., Sanguinetti M., Gillini L., De Luca A., Posteraro B., Ardito F., Fadda G., Ortona L. Application of molecular methods for detection and transmission analysis of Mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. J. Infect. Dis. 10:1999;1025-1029.
98. O'Brien K.L., Dietz H.C., Romahnoli M., Eiden J. Evaluation of inhA gene and catalase-peroxidase gene among isoniazid-sensitive and resistant Mycobacterium tuberculosis isolates. Mol. Cell Probes. 119:1996;1-6.
99. Kapur V., Li L.L., Hamrick M.R., Plikaytis B.B., Shinnick T.M., Telenti A., William R., Jacobs W.R. Jr., Banerjee A., Cole S., Kreiswirth B.N., Musser J.M. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch. Pathol. Lab. M. 1:1995;131-138.
100. Dobner P., Rusch-Gerdes S., Bretzel G., Feldmann K., Rifai M., Loscher T., Rinder H. Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isoniazid resistance. Int. J. Tuberc. Lung Dis. 171:1997;365-369.
101. Morris S., Bai G.H., Suffys P., Portillo-Gomez L., Fairchok M., Rouse D. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis. 174:1995;954-960.
102. Mdluli K., Sherman D.R., Hickey M.J., Kreiswirth B.N., Morris S., Stover C.K., Barry III C.E. Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. J. Infect. Dis. 43:1996;1085-1090.
103. McMurry L.M., McDermott P.F., Levy S.B. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob. Agents Chemother. 280:1999;711-713.
104. Mdluli K., Slayden R.A., Zhu Y., Ramaswamy S., Pan X., Mead D., Crane D.D., Musser J.M., Barry III C.E. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science. 96:1998;1607-1610.
105. Wilson M., Derisi J., Kristensen H.H., Imboden P., Rane S., Brown P.O., Schoolnik G.K. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc. Natl. Acad. Sci. USA. 43:1999;12833-12838.
106. Lee A.S., Lim I.H., Tang L.L., Telenti A., Wong S.Y. Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in singapore. Antimicrob. Agents Chemother. 6:1999;2087-2089.
107. Geistlich M., Losick R., Turner J.R., Rao R.N. Characterization of a novel regulatory gene governing the expression of a polyketide synthase gene in Streptomyces ambofaciens. Mol. Microbiol. 96:1992;2019-2029.
108. Liu J., Nikaido H. A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates. Proc. Natl. Acad. Sci. USA. 118:1999;4011-4016.
109. Takayama K., Armstrong E.L., Davidson L.A., Kunugi K.A., Kilburn J.O. Effect of low temperature on growth, viability, synthesis of mycolic acids of Mycobacterium tuberculosis strain H37Ra. Am. Rev. Respir. Dis. 1978;113-117.